PRe-clinicAl studies of a PSA-based human vaccine candidate targeting visceral, cutaneOus and mucocutaneous Leishmaniasis and Development of the associated procedures for further clinical trials

Project Information

RAPSODI

Grant agreement ID: 223341

Project closed

Start date 1 January 2009

End date 30 June 2012

Funded under

• Specific Programme "Cooperation": Health

Total cost € 4 004 911,30

EU contribution € 2 737 149,00

Coordinated by

VIRBAC SA
France